연구성과로 돌아가기
JCR 2022 저널 목록 (166 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific Journal of Ophthalmology | ASIA-PACIFIC ACAD OPHTHALMOLOGY-APAO | N/A | 2162-0989 | SCIE | OPHTHALMOLOGY | 1,875 | 4.3 | Q1 | 12.1 | 87.9 | 8/62 | 4.0 | Q1 | 3.6 | 1.2 | 0.96 | 33/95 | Q2 | 65.79 | 0.003 | 0.658 | 0.998 | Q1 | 53 | 45.3% | 3.9 | 5.1 | 24 | 97.9% | 2025-04-21 10:21:59 | 바로가기 |
| CLINICAL CHEMISTRY AND LABORATORY MEDICINE | WALTER DE GRUYTER GMBH | 1434-6621 | 1437-4331 | SCIE | MEDICAL LABORATORY TECHNOLOGY | 12,403 | 6.8 | Q1 | 12.1 | 87.9 | 4/29 | 5.1 | Q1 | 5.7 | 1.5 | 1.99 | 3/32 | Q1 | 92.19 | 0.010 | 2.251 | 1.019 | Q1 | 264 | 80.3% | 6.0 | 5.7 | 212 | 17.0% | 2025-04-21 10:15:11 | 바로가기 |
| COLLOIDS AND SURFACES B-BIOINTERFACES | ELSEVIER | 0927-7765 | 1873-4367 | SCIE | BIOPHYSICS | 42,388 | 5.8 | Q1 | 12.1 | 87.9 | 9/70 | 5.4 | Q1 | 5.6 | 1.2 | 1.12 | 8/74 | Q1 | 89.86 | 0.023 | 5.070 | 0.695 | Q2 | 663 | 98.9% | 5.9 | 5.6 | 656 | 7.6% | 2025-04-21 09:34:19 | 바로가기 |
| Dermatitis | MARY ANN LIEBERT, INC | 1710-3568 | 2162-5220 | SCIE | DERMATOLOGY | 2,223 | 5.2 | Q1 | 12.1 | 87.9 | 9/70 | 4.7 | Q1 | 4.6 | 1.0 | 2.13 | 5/93 | Q1 | 95.16 | 0.003 | 0.584 | 1.246 | Q1 | 69 | 73.9% | 5.2 | 8.2 | 51 | 9.5% | 2025-04-21 09:44:54 | 바로가기 |
| DIABETES | AMER DIABETES ASSOC | 0012-1797 | 1939-327X | SCIE | ENDOCRINOLOGY & METABOLISM | 55,263 | 7.7 | Q1 | 12.1 | 87.9 | 18/145 | 8.2 | Q1 | 7.5 | 2.4 | 1.69 | 12/184 | Q1 | 93.75 | 0.028 | 6.069 | 2.555 | Q1 | 219 | 100.0% | 12.3 | 8.2 | 219 | 1.0% | 2025-04-21 09:50:12 | 바로가기 |
| EXPERT OPINION ON INVESTIGATIONAL DRUGS | TAYLOR & FRANCIS LTD | 1354-3784 | 1744-7658 | SCIE | PHARMACOLOGY & PHARMACY | 6,364 | 6.1 | Q1 | 12.1 | 87.9 | 34/278 | 5.5 | Q1 | 6.1 | 1.3 | 1.08 | 72/366 | Q1 | 80.46 | 0.005 | 1.159 | 1.198 | Q1 | 78 | 34.6% | 7.0 | 5.0 | 27 | 11.9% | 2025-04-21 10:24:19 | 바로가기 |
| IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING | IEEE COMPUTER SOC | 1041-4347 | 1558-2191 | SCIE | COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE | 23,810 | 8.9 | Q1 | 12.1 | 87.9 | 18/145 | 8.9 | Q1 | 8.6 | 6.0 | 1.83 | 19/192 | Q1 | 90.36 | 0.018 | 3.914 | 2.057 | Q1 | 430 | 99.8% | 6.2 | 7.8 | 429 | 9.8% | 2025-04-21 09:40:43 | 바로가기 |
| International Journal of Biological Macromolecules | ELSEVIER | 0141-8130 | 1879-0003 | SCIE | BIOCHEMISTRY & MOLECULAR BIOLOGY | 131,764 | 8.2 | Q1 | 12.1 | 87.9 | 35/285 | 7.8 | Q1 | 7.4 | 1.7 | 1.44 | 36/315 | Q1 | 88.73 | 0.108 | 23.454 | 0.920 | Q2 | 2819 | 92.3% | 3.3 | 5.4 | 2603 | 4.5% | 2025-04-21 09:33:21 | 바로가기 |
| Journal of Allergy and Clinical Immunology-In Practice | ELSEVIER | 2213-2198 | 2213-2201 | SCIE | IMMUNOLOGY | 13,968 | 9.4 | Q1 | 12.1 | 87.9 | 20/161 | 8.7 | Q1 | 8.5 | 2.7 | 1.47 | 24/177 | Q1 | 86.72 | 0.031 | 6.646 | 2.711 | Q1 | 292 | 67.8% | 3.0 | 6.0 | 198 | 19.3% | 2025-04-21 10:04:25 | 바로가기 |
| JOURNAL OF THE AMERICAN CERAMIC SOCIETY | WILEY | 0002-7820 | 1551-2916 | SCIE | MATERIALS SCIENCE, CERAMICS | 52,540 | 3.9 | Q1 | 12.1 | 87.9 | 4/29 | 3.8 | Q1 | 3.6 | 0.6 | 0.92 | 4/30 | Q1 | 88.33 | 0.020 | 4.431 | 0.672 | Q1 | 642 | 99.4% | 13.5 | 8.0 | 638 | 8.7% | 2025-04-21 10:11:01 | 바로가기 |
| LIFE SCIENCES | PERGAMON-ELSEVIER SCIENCE LTD | 0024-3205 | 1879-0631 | SCIE | PHARMACOLOGY & PHARMACY | 44,616 | 6.1 | Q1 | 12.1 | 87.9 | 34/278 | 5.8 | Q1 | 6.0 | 1.2 | 1.43 | 31/366 | Q1 | 91.67 | 0.036 | 7.804 | 0.912 | Q2 | 818 | 82.6% | 4.1 | 6.8 | 676 | 8.0% | 2025-04-21 10:24:05 | 바로가기 |
| npj Vaccines | NATURE PORTFOLIO | N/A | 2059-0105 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 3,551 | 9.2 | Q1 | 12.1 | 87.9 | 17/136 | 8.5 | Q1 | 8.8 | 1.6 | 1.73 | 14/190 | Q1 | 92.89 | 0.010 | 2.073 | 2.831 | Q1 | 163 | 92.6% | 2.0 | 5.2 | 151 | 100.0% | 2025-04-21 10:16:21 | 바로가기 |
| Philosophy Ethics and Humanities in Medicine | BMC | 1747-5341 | 1747-5341 | SCIE | HISTORY & PHILOSOPHY OF SCIENCE | 383 | 1.9 | Q1 | 12.1 | 87.9 | 8/62 | 2.3 | Q1 | 1.9 | 0.6 | 1.30 | 16/106 | Q1 | 85.38 | 0.000 | 0.091 | 0.777 | Q1 | 16 | 75.0% | 8.6 | 9.3 | 12 | 100.0% | 2025-04-21 10:01:21 | 바로가기 |
| Progress of Theoretical and Experimental Physics | OXFORD UNIV PRESS INC | 2050-3911 | N/A | SCIE | PHYSICS, PARTICLES & FIELDS | 5,313 | 8.3 | Q1 | 12.1 | 87.9 | 4/29 | 4.6 | Q1 | 7.9 | 1.0 | 1.03 | 11/31 | Q2 | 66.13 | 0.012 | 2.603 | 1.648 | Q1 | 179 | 99.4% | 2.8 | 12.1 | 178 | 93.0% | 2025-04-21 10:26:39 | 바로가기 |
| Propulsion and Power Research | KEAI PUBLISHING LTD | 2212-540X | 2212-540X | SCIE | ENGINEERING, MECHANICAL | 1,164 | 5.3 | Q1 | 12.1 | 87.9 | 17/136 | 5.2 | Q1 | 5.0 | 1.1 | 1.33 | 18/179 | Q1 | 90.22 | 0.001 | 0.198 | 0.644 | Q2 | 36 | 94.4% | 4.3 | 8.2 | 34 | 96.0% | 2025-04-21 09:54:12 | 바로가기 |
페이지 이동: